other material
confidence high
sentiment positive
materiality 0.90
Plus Therapeutics cuts Series B warrant shares from 1.26B to 35.5M; cancels Series A warrants
PLUS THERAPEUTICS, INC.
- Cancelled all Series A warrants exercisable for up to 280M shares of common stock.
- Series B warrants amended to reduce total shares issuable from ~1.26B to ~35.5M; cashless exercise ratio cut from 3:1 to 1:1.
- Investors agreed to return ~12.2M Private Placement Shares and Pre-Funded Warrants in exchange for 115% repayment from future capital raises.
- Registration Rights Agreement terminated; restrictions on subsequent equity sales waived.